Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.33 |
| ▸ | CES2 | O00748 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PAM | P19021 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28171221 | 0.94 | CYP4F2 (0.34) | CYP4F2CYP4A11FDPSEPHX1CES2 | |
| Phosphonic Acid SCHEMBL28171187 | 0.92 | CYP4F2 (0.33) | CYP4F2CYP4A11FDPSMEN1MAPT | |
| SCHEMBL27738047 | 0.84 | CYP4F2 (0.49) | CYP4F2CYP4A11FDPSEPHX1CES2 | |
| SCHEMBL10814845 | 0.81 | CYP4F2 (0.39) | CYP4F2CYP4A11FDPSEPHX1CES2 | |
| SCHEMBL28170608 | 0.80 | LMNA (0.31) | — | |
| SCHEMBL27614308 | 0.79 | CYP4F2 (0.38) | CYP4F2CYP4A11FDPSEPHX1CES2 | |
| SCHEMBL28730000 | 0.79 | EPHX1 (0.43) | CYP4F2CYP4A11FDPSEPHX1CES2 | |
| Phosphonic Acid SCHEMBL28170559 | 0.78 | LMNA (0.31) | — | |
| SCHEMBL2128371 | 0.77 | CYP4F2 (0.37) | CYP4F2CYP4A11FDPSEPHX1CES2 | |
| SCHEMBL2128373 | 0.77 | CYP4F2 (0.37) | CYP4F2CYP4A11FDPSEPHX1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3166981-B1 | OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2026-05-13 | — | — | EP | disclosed |
| US-12514267-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2026-01-06 | — | — | US | disclosed |
| US-20250057202-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2025-02-20 | — | — | US | disclosed |
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | MIDORI USA, INC. | 2023-08-17 | — | — | US | disclosed |
| EP-4205553-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | DSM Nutritional Products, LLC (US) | 2023-07-05 | — | — | EP | disclosed |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-05-23 | — | — | US | disclosed |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | DSM NUTRITIONAL PRODUCTS, LLC (US) | 2023-02-21 | — | — | US | disclosed |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | DSM NUTRITIONAL PRODUCTS, LLC | 2022-12-29 | — | — | US | disclosed |
| US-20220400728-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-12-22 | — | — | US | disclosed |
| EP-3636077-B1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF | CADENA BIO INC (US) | 2022-11-16 | — | — | EP | disclosed |
| CN-103917569-B | Polyurethane-base barrier film and/or spacer body for electrochemical cell | 路博润高级材料公司 | 2018-04-10 | — | — | CN | disclosed |
| EP-0938462-A1 | HYDROXYALKYLATION OF PHENOLS | Reichhold Chemicals, Inc. (US) | 1999-09-01 | — | — | EP | disclosed |
| EP-0929593-A1 | PROCESS FOR PREPARING ESTERIFICATION PRODUCTS | Reichhold Chemicals, Inc. (US) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998013409-A1 | PROCESS FOR PREPARING ESTERIFICATION PRODUCTS | REICHHOLD CHEMICALS, INC. (US) | 1998-04-02 | — | — | WO | disclosed |
| WO-1998013327-A1 | HYDROXYALKYLATION OF PHENOLS | REICHHOLD CHEMICALS, INC. (US) | 1998-04-02 | — | — | WO | disclosed |
| US-5714568-A | BY-PRODUCT INHIBITION, DISCOLORATION INHIBITION | REICHHOLD CHEMICALS, INC. (US) | 1998-02-03 | — | — | US | disclosed |
| US-5679871-A | Hydroxyalklylation of phenols | REICHHOLD CHEMICALS, INC. (US) | 1997-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255240-A1 | OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF | FUT5, FUT6, OSTC | CYP4F2 729/4885CYP4A11 1964/4885FDPS 373/4885 |
| US-11584805-B2 | Oligosaccharide compositions and methods for producing thereof | OSTC, FUT5, FUT6 | CYP4F2 1188/4885CYP4A11 2718/4885FDPS 582/4885 |
| US-11653676-B2 | Oligosaccharide compositions for use as animal feed and methods of producing thereof | FUT5, FUT6, OSTC | CYP4F2 729/4885CYP4A11 1964/4885FDPS 373/4885 |
| US-20220409644-A1 | ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE | FUT6, FUT5, PIGS | CYP4F2 3269/4885CYP4A11 4324/4885FDPS 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.